Jim Simons Jasper Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.42 - $0.93 $85,727 - $189,824	204,112 Added 65.8%	514,324 $406,000
Q3 2023 Nov 14, 2023	BUY	$0.68 - $1.54 $171,436 - $388,252	252,112 Added 433.93%	310,212 $217,000
Q2 2023 Aug 11, 2023	SELL	$1.19 - $1.79 $61,999 - $93,259	-52,100 Reduced 47.28%	58,100 $80,000
Q1 2023 May 12, 2023	BUY	$1.48 - $2.74 $66,304 - $122,752	44,800 Added 68.5%	110,200 $199,000
Q4 2022 Feb 13, 2023	BUY	$0.46 - $8.9 $16,928 - $327,520	36,800 Added 128.67%	65,400 $32,000
Q3 2022 Nov 14, 2022	BUY	$0.08 - $22.6 $2,288 - $646,360	28,600 New	28,600 $23,000
Q2 2022 Aug 12, 2022	SELL	$1.73 - $3.86 $18,806 - $41,962	-10,871 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.96 - $8.01 $32,178 - $87,076	10,871 New	10,871 $39,000

5.63M

Ticker JSPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,073,300
Market Cap $829M
Description
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a techniqu...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.